Applied Biosystems Announces Enhanced Version of Industry Leading SQL*LIMS Software.Business Editors/Health/Medical Writers BIOWIRE2K Pittcon 2004 FOSTER CITY, Calif.--(BUSINESS WIRE)--March 8, 2004 The First Fully Web Enabled Laboratory Information Management System Introduced at PITTCON 2004 Applied Biosystems Applied Biosystems, Inc. (formerly NASDAQ: ABIO) is the original name of a pioneer biotechnology company founded in 1981 in Foster City, California, among the Silicon Valley cities of the southern San Francisco Bay Area. (NYSE NYSE See: New York Stock Exchange :ABI Abi (ā`bī) [short for Abijah], in the Bible, King Hezekiah's mother. (Application Binary Interface) A specification for a specific hardware platform combined with the operating system. ), an Applera Corporation business, today announced the latest version of its laboratory information management system (LIMS LIMS Laboratory Information Management System LIMS Library Information Management System LIMS Limb Infrared Monitor of the Stratosphere LIMS Land Information Management System (Canada) LIMS Logistics Information Management System ) software, SQL SQL in full Structured Query Language. Computer programming language used for retrieving records or parts of records in databases and performing various calculations before displaying the results. *LIMS(TM) version 5.0. The latest version of the software includes an enhanced user interface delivered via a Web services application that provides a comprehensive, enterprise-accessible productivity solution for pharmaceutical manufacturing organizations. Additionally, the new SQL*LIMS(TM) software includes enhancements, such as instrument calibration, user qualification and reagent inventory tracking. SQL*LIMS(TM) software, installed in more than 1,000 laboratories worldwide, is a complete laboratory information management system that automates sample tracking, laboratory processes and workflow, data access and storage, and regulatory compliance. The new, open platform Web services application was built using industry standard technology including the Oracle(R) Application Server 10g, Database 9i and provides an extensible J2EE (Java 2 Platform, Enterprise Edition) A platform from Sun for building distributed enterprise applications. J2EE services are performed in the middle tier between the user's machine and the enterprise's databases and legacy information systems. standards-based application. Additionally, Applied Biosystems expects to deliver a series of new product updates to SQL*LIMS(TM) software version 5.0 over the coming months. "The latest version of our SQL*LIMS(TM) product offers pharmaceutical R&D organizations an enterprise-accessible system that should enable increased productivity across manufacturing groups and even global sites," said Michael W. Hunkapiller, Ph.D., President of Applied Biosystems. "As a result, decisions about such important issues as drug formulation, production stability, and product lot quality can be made more easily and efficiently within a system that supports regulatory compliance requirements." "Typically, LIMS applications have required installation on local user machines, making the systems more costly to implement and maintain. With the introduction of the Web-enabled SQL*LIMS(TM) version 5.0, customers should be able to reduce their total cost of ownership with a configurable system that is easy to distribute, maintain and connect to other mission critical applications, while still securely protecting data quality and integrity," said Bruce von Herrmann, Vice President and General Manager of Global Informatics Software and Professional Services for Applied Biosystems. The Global Informatics Software and Professional Services Group of Applied Biosystems provides specialized, scalable and flexible solutions for data handling, instrument integration and process automation, as well as professional services to help customers design and implement informatics solutions for both discovery research as well as development and manufacturing. About Applera Corporation and Applied Biosystems Applera Corporation consists of two operating groups. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids Nucleic acids The cellular molecules DNA and RNA that act as coded instructions for the production of proteins and are copied for transmission of inherited traits. (DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. and RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic ), small molecules, and proteins to make scientific discoveries, develop new pharmaceuticals, and conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.7 billion during fiscal 2003. The Celera Genomics Group (NYSE:CRA See Community Reinvestment Act. ), located in Rockville, MD, and South San Francisco South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , CA, is engaged principally in integrating advanced technologies to discover and develop new therapeutics. Celera intends to leverage its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets, and to discover and develop new therapeutics. Its Celera Discovery System(TM) online platform, marketed exclusively by Applied Biosystems, is an integrated source of information based on the human genome and other biological and medical sources. Celera Diagnostics, a 50/50 joint venture between Applied Biosystems and Celera Genomics, is focused on discovery, development, and commercialization of novel diagnostic products. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800.762.6923. Information about Applied Biosystems is available at http://www.appliedbiosystems.com/. Certain statements in this press release are forward-looking. These may be identified by the use of forward-looking words or phrases such as "should," among others. These forward-looking statements are based on Applera Corporation's current expectations. The Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 provides a "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " for such forward-looking statements. In order to comply with the terms of the safe harbor, Applera Corporation notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. These factors include but are not limited to (1) rapidly changing technology and dependence on development of new products; (2) claims for patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. ; (3) sales dependent on customers' capital spending capital spending Spending for long-term assets such as factories, equipment, machinery, and buildings that permits the production of more goods and services in future years. policies and government-sponsored research; (4) dependence on continuous, effective, reliable, and secure operation of its computer hardware, software, and Internet applications and related tools and functions; and (5) other factors that might be described from time to time in Applera Corporation's filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and Applera does not undertake any duty to update this information, including any forward-looking statements, unless required by law. Applied Biosystems is a registered trademark and Applera, Celera, Celera Diagnostics, Celera Discovery System, Celera Genomics, and SQL*LIMS are trademarks of Applera Corporation or its subsidiaries in the U.S. and/or certain other countries. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion